使用哈里斯-本尼迪克特方程诊断的低能量摄入与老年心力衰竭患者的预后不佳有关
Akira Taruya1,2, Tsuyoshi Nishiguchi3, Shingo Ota1
1Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama 641-0012, Japan.
Journal of clinical medicine
|November 25, 2023
概括
老年心力衰竭患者的能量摄入量较低,死亡率较高. 使用哈里斯-本尼迪克特方程进行能量评估可能会改善这些患者的治疗结果.
科学领域:
- 老年病的医生 老年病的医生
- 心脏病学 心脏病学
- 营养科学 营养科学
背景情况:
- 营养摄入不足是老年心力衰竭患者死亡率的重要预测因素.
- 在这个人群中,能量摄入对预后的具体影响仍然不清楚.
- 这项研究检查了心力衰竭的老年人能量摄入量和结果之间的关系.
研究的目的:
- 为了研究心力衰竭诊断的老年人 (≥65岁) 测量能量摄入量和患者结果之间的关联.
- 为了确定能量摄入水平是否影响死亡率和医院再入院率.
- 评估哈里斯 - 贝尼迪克特方程在评估心力衰竭管理的能量需求中的实用性.
主要方法:
- 139名因心力衰竭恶化而住院的老年患者被纳入.
- 在三天内测量了能量摄入量.
- 根据使用哈里斯-本尼迪克特方程计算的基础能量消耗,患者被分为低能量 (n=38) 和高能量 (n=101) 组.
主要成果:
- 与高能量的组相比,低能量的组包括更多的女性,更少的吸烟者,并且患有较少的缺血性心脏病和较高的左心室喷射率.
- 低能耗组经历了显著更高的全因死亡率 (p=0.028).
- 由于心力衰竭恶化而导致的再入院的主要结果在两组之间没有显著差异 (p=0.569).
结论:
- 虽然主要结局 (再入院) 没有差异,但较低的能量摄入与老年心力衰竭患者的死亡率增加有关.
- 使用哈里斯 - 贝尼迪克特方程进行能量需求评估,可能有助于管理老年心力衰竭患者.
- 这种方法可能会为这个弱势群体带来更好的生活结果.
更多相关视频
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
1.9K
10:21Evaluation of Hydration Status by Bioelectrical Impedance Vector Analysis in Patients with Ischemic Heart Disease Undergoing Exercise Stress Test
Published on: September 22, 2023
654
相关概念视频
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:22Heart Failure Drugs: β-Blockers
342
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
342
01:22Heart Failure Drugs: Diuretics
396
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
396
01:11Renal Failure: Dose Adjustments
95
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
95